RESEARCHERS TO TRIAL GROUND-BREAKING SCREENING TEST FOR PRE-ECLAMPSIA

Researchers are launching the STARshiP study, a large-scale trial involving 200,000 women to test a new screening method for pre-eclampsia, a condition affecting pregnant women and their unborn babies. Led by Saint Mary’s Managed Clinical Service in collaboration with Manchester University NHS Foundation Trust, The University of Manchester, and Nottingham Clinical Trials Unit, the study aims to improve early detection and prevention of pre-eclampsia. Funded by NIHR and sponsored by The University of Manchester, the trial will use a combined screening technique during early pregnancy scans and a blood test. High-risk individuals will receive aspirin treatment to reduce the condition’s incidence. The study will be implemented across participating hospitals using a stepped wedge clinical trial design.

0

Quiz Thirty Six

1 / 5

Which of the following is a common symptom of pre-eclampsia that the screening test might help detect?

Decreased appetite

Mild cramping

Frequent nausea

Severe headache and swelling

2 / 5

What is a potential advantage of the ground-breaking screening test over traditional methods?

It replaces all other prenatal care

It offers earlier and potentially more accurate detection of pre-eclampsia

It provides results later in pregnancy

It is less expensive but less accurate

3 / 5

Why is early detection of pre-eclampsia important for pregnant women?

To prevent weight gain

To shorten the length of pregnancy

To manage and reduce the risk of complications for both the mother and the baby

To avoid unnecessary tests

4 / 5

What condition does the screening test aim to identify?

Premature labor

Placental abruption

Pre-eclampsia

Gestational diabetes

5 / 5

What is the primary purpose of the new screening test being trialed for pre-eclampsia?

To prevent pregnancy complications unrelated to pre-eclampsia

To treat pre-eclampsia symptoms

To predict and detect pre-eclampsia earlier in pregnancy

To diagnose pre-eclampsia after delivery

Your score is

LinkedIn Facebook Twitter VKontakte

Read More